TIMP1 and metabolic dysfunction-associated steatohepatitis: In fact, TIMP1 was found to be an independent predictor of fibrosis in NAFLD patients [240] and TIMP1 plasmatic levels were recently shown to be significantly correlated to the percentage of fibrosis in a mouse model of NASH [241].